These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 358737)

  • 1. Long-term prophylaxis with methenamine hippurate in girls with recurrent urinary tract infections.
    Petersen S
    Acta Paediatr Scand; 1978 Sep; 67(5):597-9. PubMed ID: 358737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with methenamine hippurate in recurrent urinary tract infection.
    Nilsson S
    Acta Med Scand; 1975; 198(1-2):81-5. PubMed ID: 1166827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of recurrent urinary tract infections. Comparison of the effect of placebo, methenamine hippurate, nitrofurantoin and trimethoprim alone.
    Kasanen A; Junnila SY; Kaarsalo E; Hajba A; Sundquist H
    Scand J Infect Dis; 1982; 14(4):293-6. PubMed ID: 6761854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical testing of methenamine hippurate (Hiprex) in the treatment of urinary tract infections].
    Bengtsson U; Orsten PA
    Lakartidningen; 1973 Dec; 70(49):4517-9. PubMed ID: 4595775
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of recurrent urinary infections in women: a comparative trial between nitrofurantoin and methenamine hippurate.
    Brumfitt W; Cooper J; Hamilton-Miller JM
    J Urol; 1981 Jul; 126(1):71-4. PubMed ID: 7019458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial.
    King W; Homer T; Harding C; Mossop H; Chadwick T; Abouhajar A; Vale L
    BMJ Open; 2024 Apr; 14(4):e074445. PubMed ID: 38684270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methenamine hippurate. Short-term catheterization in gynecologic surgery. A double-blind comparison of Hiprex and placebo].
    Knoff T
    Tidsskr Nor Laegeforen; 1985 Mar; 105(7):498-9. PubMed ID: 3887639
    [No Abstract]   [Full Text] [Related]  

  • 8. Methenamine hippurate (Hiprex).
    Med Lett Drugs Ther; 1968 Jul; 10(15):58-60. PubMed ID: 4875552
    [No Abstract]   [Full Text] [Related]  

  • 9. Methenamine hippurate compared with trimethoprim for the prevention of recurrent urinary tract infections: a randomized clinical trial.
    Botros C; Lozo S; Iyer S; Warren A; Goldberg R; Tomezsko J; Sasso K; Sand P; Gafni-Kane A; Biener A; Botros-Brey S
    Int Urogynecol J; 2022 Mar; 33(3):571-580. PubMed ID: 34115162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial comparing co-trimoxazole and methenamine hippurate in the prevention of recurrent urinary tract infections.
    Kalowski S; Nanra RS; Friedman A; Radford N; Standish H; Kincaid-Smith P
    Med J Aust; 1975 May; 1(19):585-9. PubMed ID: 1152707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methenamine hippurate in urinary tract infections].
    Klein D; Puchegger R
    ZFA (Stuttgart); 1976 Jul; 52(21):1110-4. PubMed ID: 785852
    [No Abstract]   [Full Text] [Related]  

  • 12. Urinary tract infection after vaginal surgery. Effect of prophylactic treatment with methenamine hippurate.
    Tyreman NO; Andersson PO; Kroon L; Orstam S
    Acta Obstet Gynecol Scand; 1986; 65(7):731-3. PubMed ID: 3544661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial.
    Harding C; Mossop H; Homer T; Chadwick T; King W; Carnell S; Lecouturier J; Abouhajar A; Vale L; Watson G; Forbes R; Currer S; Pickard R; Eardley I; Pearce I; Thiruchelvam N; Guerrero K; Walton K; Hussain Z; Lazarowicz H; Ali A
    BMJ; 2022 Mar; 376():e068229. PubMed ID: 35264408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prophylaxis of urinary infections in women: comparative trial of trimethoprim, methenamine hippurate and topical povidone-iodine.
    Brumfitt W; Hamilton-Miller JM; Gargan RA; Cooper J; Smith GW
    J Urol; 1983 Dec; 130(6):1110-4. PubMed ID: 6227756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The resurgence of methenamine hippurate in the prevention of recurrent UTIs in women- a systematic review.
    Kale S; Somani BK
    Curr Opin Urol; 2023 Nov; 33(6):488-496. PubMed ID: 37337660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of hexamine hippurate and hexamine mandelate in prevention of recurrent infection of the urinary tract.
    Gow JG
    Practitioner; 1974 Jul; 213(1273):97-101. PubMed ID: 4280569
    [No Abstract]   [Full Text] [Related]  

  • 17. Methenamine hippurate for preventing urinary tract infections.
    Lee B; Bhuta T; Craig J; Simpson J
    Cochrane Database Syst Rev; 2002; (1):CD003265. PubMed ID: 11869659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nitrofurantoin and methenamine hippurate prophylaxis on bacteria and yeasts in the urine of patients with an indwelling catheter.
    Kostiala AA; Nyrén P; Runeberg L
    J Hosp Infect; 1982 Dec; 3(4):357-64. PubMed ID: 6190868
    [No Abstract]   [Full Text] [Related]  

  • 19. Methenamine hippurate for preventing urinary tract infections.
    Lee BB; Simpson JM; Craig JC; Bhuta T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD003265. PubMed ID: 17943785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effectiveness of methenamine hippurate and nitrofurantoin in the prevention of recurrence of urinary tract infections].
    Krzymanski M; Grabski T; Suwała W
    Pol Arch Med Wewn; 1982; 67(1-2):23-8. PubMed ID: 7111046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.